Global and national laboratory networks support high quality surveillance for measles and rubella
- PMID: 28582561
- DOI: 10.1093/inthealth/ihx017
Global and national laboratory networks support high quality surveillance for measles and rubella
Abstract
Laboratory networks are an essential component of disease surveillance systems because they provide accurate and timely confirmation of infection. WHO coordinates global laboratory surveillance of vaccine preventable diseases, including measles and rubella. The more than 700 laboratories within the WHO Global Measles and Rubella Laboratory Network (GMRLN) supports surveillance for measles, rubella and congenial rubella syndrome in 191 counties. This paper describes the overall structure and function of the GMRLN and highlights the largest of the national laboratory networks, the China Measles and Rubella Laboratory Network.
Keywords: Laboratory diagnosis; Laboratory networks; Measles; Rubella; Surveillance networks.
Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Similar articles
-
Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):438-42. doi: 10.15585/mmwr.mm6517a3. MMWR Morb Mortal Wkly Rep. 2016. PMID: 27148917
-
Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.MMWR Morb Mortal Wkly Rep. 2019 Jul 5;68(26):587-591. doi: 10.15585/mmwr.mm6826a3. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31269012 Free PMC article.
-
Global measles and rubella laboratory network--update.Wkly Epidemiol Rec. 2005 Nov 4;80(44):384-8. Wkly Epidemiol Rec. 2005. PMID: 16300026 English, French. No abstract available.
-
Integrating measles and rubella surveillance: the experience in the Caribbean.J Infect Dis. 2003 May 15;187 Suppl 1:S153-7. doi: 10.1086/368031. J Infect Dis. 2003. PMID: 12721907 Review.
-
Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.Epidemiol Rev. 2002;24(2):125-36. doi: 10.1093/epirev/mxf002. Epidemiol Rev. 2002. PMID: 12762088 Review. No abstract available.
Cited by
-
Epidemiological characteristics of seven notifiable respiratory infectious diseases in the mainland of China: an analysis of national surveillance data from 2017 to 2021.Infect Dis Poverty. 2023 Nov 13;12(1):99. doi: 10.1186/s40249-023-01147-3. Infect Dis Poverty. 2023. PMID: 37953290 Free PMC article.
-
Epidemiological Characteristics of Notifiable Respiratory Infectious Diseases in Mainland China from 2010 to 2018.Int J Environ Res Public Health. 2023 Feb 23;20(5):3946. doi: 10.3390/ijerph20053946. Int J Environ Res Public Health. 2023. PMID: 36900957 Free PMC article.
-
Importation and circulation of rubella virus lineages 1E-L2 and 2B-L2c between 2018 and 2021 in China: Virus evolution and spatial-temporal transmission characteristics.Virus Evol. 2022 Sep 6;8(2):veac083. doi: 10.1093/ve/veac083. eCollection 2022. Virus Evol. 2022. PMID: 36533147 Free PMC article.
-
Characteristics and Genomic Diversity of Measles Virus From Measles Cases With Known Vaccination Status in Shanghai, China.Front Med (Lausanne). 2022 Jun 30;9:841650. doi: 10.3389/fmed.2022.841650. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35847814 Free PMC article.
-
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis.Lancet Infect Dis. 2021 Feb;21(2):286-295. doi: 10.1016/S1473-3099(20)30442-4. Epub 2020 Sep 1. Lancet Infect Dis. 2021. PMID: 32888410 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
